Additionally, it will be interesting to explore the effect of CK2A1 activity in the PKD2 open-gate probability under PKD2-related clinical conditions such as autosomal dominant polycystic kidney disease (42, 43). This evidence concerns the gene CSNK2A1 and autosomal dominant polycystic kidney disease.